Colorectal Cancer Screening: Early Detection Saves Lives

Colorectal Cancer Screening Campaign Underway in Besançon

A straightforward, free, and at-home test is now available to residents of Besançon and the Franche-Comté region to help detect colorectal cancer at its earliest stages. The initiative, launched by the Institut régional fédératif du cancer de Franche-Comté (IRFC), aims to increase screening rates and improve outcomes for this common, yet often preventable, cancer. Colorectal cancer, affecting both the colon and rectum, is one of the most frequently diagnosed cancers in France, impacting over 47,500 people annually and contributing to nearly 17,000 deaths in 2022, according to data from the Institut National du Cancer.

Understanding Colorectal Cancer: Incidence and Impact

In 2023 alone, 26,212 men and 21,370 women in France received a diagnosis of colorectal cancer, with median ages of 71 and 72 respectively. While it’s the third most common cancer in men (after prostate and lung cancer, representing 11.2% of new male cancer cases), it’s the second most common in women (after breast cancer, accounting for 11.3% of new female cancer cases). It remains the second leading cause of cancer-related deaths in France, responsible for approximately 12% of all cancer fatalities, particularly among those aged 65 and older.

Despite these sobering statistics, there’s encouraging news: mortality rates have been steadily declining since 1980. This improvement is largely attributed to increased access to colorectal cancer screening and the removal of precancerous lesions. In the majority of cases – around 80% – colorectal cancer develops from benign tumors that slowly evolve into cancerous growths.

The Power of Early Detection: A 9 in 10 Chance of Cure

Early detection is critical. Screening is recommended for individuals aged 50 to 74, and involves a simple immunological test performed at home using a stool sample. The test is readily available free of charge from your primary care physician, a pharmacist, or a gastroenterologist, and can also be ordered online. When detected early, colorectal cancer boasts a remarkably high cure rate – approximately 9 out of 10 cases.

Bridging the Gap: Outreach Efforts in the Franche-Comté Region

Despite the proven benefits of screening, participation rates remain low, with only about one in three eligible individuals taking advantage of the opportunity. To address this, the gastroenterology teams from the CHU Besançon Franche-Comté are actively engaging with the public through a series of “Mardis bleus” (Blue Tuesdays) events throughout March.

These outreach events are taking place at various locations, including Super U de l’Amitié, Carrefour de Chalezeule (March 24th, 9am-1pm), and Galerie Châteaufarine (March 31st, 9am-1pm). These events provide a valuable opportunity to speak directly with healthcare professionals and receive accurate information about colorectal cancer screening. The IRFC and partner laboratories, Pierre Fabre, are also collaborating with artist Jordane Saget, who has created a striking art installation titled “lines of life” in the Jean Minjoz hospital lobby to raise awareness.

Understanding the Screening Process and Test Details

The recommended screening test is an immunological fecal test, which detects hidden blood in the stool. This blood can be a sign of polyps or early-stage cancer. It’s important to understand that a positive result doesn’t automatically mean cancer is present; further investigation, such as a colonoscopy, is needed to determine the cause. The IRFC website provides more detailed information about the screening process and what to expect.

Colorectal Cancer: A Closer Look at Risk Factors and Mortality Trends

While anyone can develop colorectal cancer, certain factors can increase your risk. These include age, family history of the disease, inflammatory bowel disease, and lifestyle factors such as diet, physical activity, and smoking. The decline in mortality rates observed over the past two decades is a testament to the effectiveness of screening programs and advancements in treatment. Between 2012 and 2022, mortality rates decreased by 2% in men and 1.5% in women.

What to Do Next: Prioritizing Preventative Health

If you are between the ages of 50 and 74, discuss colorectal cancer screening with your doctor. Don’t hesitate to ask questions and address any concerns you may have. Early detection is the most powerful tool we have in the fight against this disease. For more information on colorectal cancer and screening options, consult your healthcare provider or visit the Institut régional fédératif du cancer de Franche-Comté website or the Institut National du Cancer.